Immunotherapy for metastatic prostate cancer: Immuno-cold or the tip of the iceberg?

Purpose of reviewMetastatic castration-resistant prostate cancer is in critical need of new and innovative treatment strategies. Since the approval of sipuleucel-T, the investigatory climate of prostate cancer immunotherapy has been rapidly evolving with promising developments in vaccine and immune